# Study Evaluating the Gastrointestinal Safety of PLA-695 Compared to Placebo and Naproxen

> **NCT00366262** · PHASE1 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer**

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PLA-695
- **DRUG:** Naproxen
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00366262
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** —
- **Final completion:** 2007-03
- **Target enrollment:** — (—)
- **Last updated:** 2008-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00366262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00366262, "Study Evaluating the Gastrointestinal Safety of PLA-695 Compared to Placebo and Naproxen". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00366262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*